Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth
Conclusion: Gigantol was found to inhibit lung cancer proliferation through induction of GSK3β-mediated MYC ubiquitin-proteasome degradation. These data suggest gigantol to be a promising candidate for novel strategy in inhibition of lung cancer.
Source: Cancer Genomics and Proteomics - Category: Cancer & Oncology Authors: LOSUWANNARAK, N., ROYTRAKUL, S., CHANVORACHOTE, P. Tags: Experimental Studies Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Lung Cancer | Stem Cell Therapy | Stem Cells | Study | Toxicology